MHRA Class 3 Medicines Recall: Bimatoprost 0.3mg/ml eye drops, solution in single dose container 0.4ml x 30 (Aspire Pharma)

MHRA Class 3 Medicines Recall: Bimatoprost 0.3mg/ml eye drops, solution in single dose container 0.4ml x 30 (Aspire Pharma)

October 26, 2021

Class 3 Medicines recall: Bimatoprost 0.3mg/ml eye drops, solution in single dose container 0.4ml x 30 (Aspire Pharma)

Drug alert number: EL (21) A/26

Date issued: 26th October 2021

The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for:

Bimatoprost 0.3mg/ml eye drops, solution in single dose container 0.4ml x 30 (Aspire Pharma) PL 35533/0128

Aspire Pharma Limited is recalling the below batches of Bimatoprost Aspire 0.3mg/ml eye drops, solution in single dose container 0.4ml x 30 as a precautionary measure due to the identification of some variability in the thickness of plastic of the single dose containers resulting in some patients finding the containers difficult to squeeze due to increased hardness of individual containers.

Batch Number Expiry Date Pack Size First Distributed
1590121 31/01/2023 30 04/03/2021
1590221 31/01/2023 30 07/05/2021
1590321 31/01/2023 30 28/06/2021
1593920 31/01/2023 30 05/08/2021
1594020 31/01/2023 30 21/09/2021

Advice for healthcare professionals

  • Stop supplying the batches listed above immediately.
  • Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Full drug alert can be viewed here.

Company contacts for further information

For more information please contact: Customer Services for stock control enquiries: customerservices@aspirepharma.co.uk ; Tel. 01730 231148 or for Medical Information enquiries: medinfo@aspirepharma.co.uk ; Tel. 01730 231148

 

 



Posted in:


More Latest News >